Each tablet contains Citicoline 500 mg.

Nurocol Tablets contain Citicoline, a neuroprotective and nootropic agent that supports neuronal membrane repair, enhances brain metabolism, and improves cognitive function. It promotes the synthesis of essential phospholipids required for neuronal cell membrane integrity, helping restore brain function following vascular or traumatic cerebral injuries. The formulation is widely used to support neurological recovery and cognitive health in patients with cerebrovascular disorders and degenerative neurological conditions.

Nurocol Tablets are indicated for the treatment of serious cerebral injuries of vascular or traumatic origin, with or without loss of consciousness. It is also indicated for the management of degenerative brain disorders and chronic cerebrovascular diseases associated with senile dementia, helping improve cognitive function and neurological recovery.

Citicoline is a pyrimidine 5′-nucleotide that serves as a key precursor in the synthesis of phosphatidylcholine (lecithin) and other membrane phospholipids essential for neuronal cell repair and regeneration. It enhances the structural integrity and functionality of neuronal membranes, promotes membrane repair, improves cerebral metabolism, and supports neurotransmitter synthesis. These actions contribute to improved cognitive performance, neuronal survival, and recovery following cerebral injury.

The dosage should be individualized according to the patient's clinical condition. The usual recommended dose is 500–1,000 mg daily, or as directed by the physician. No dosage adjustment is generally required in elderly patients, and the standard adult dosage may be administered.

Nurocol Tablets are contraindicated in patients with known hypersensitivity to Citicoline or any component of the formulation. It is also contraindicated in patients with hypertonia of the parasympathetic nervous system.